BMW has invested about EUR 400 million in Regensburg production since 2023 and begun Gen6 battery output in Shenyang as it builds Neue Klasse capacity.

Micron Technology shares fell 6.1% on the day, caught in a worldwide selloff of AI-linked equities that has little to do with the company's own announcements. T ...

MoffettNathanson trimmed its target but kept buy; Needham downgraded to hold. Netflix cut its 2026 ad revenue forecast to ...

BioNTech plans to amend Phase 3 ROSETTA Breast-01 to test pumitamig with Gilead's Trodelvy instead of chemotherapy; the change needs regulatory approval.

Ocugen will report Q3 2026 results on 4 November 2026, a checkpoint on its OCU400 timeline and Roots licensing deal.

Micron's 6.3% drop tracked a 6.7% semiconductor selloff tied to AI capex financing worries, not its Indium deal, Taiwan labor pacts or new bonus plan.

UBTech signed a Japan distribution deal, began small U1 deliveries, and inked UAE and Xiamen C&D pacts — but only some are binding sales.

Diginex shareholders approved the Resulticks deal with 98.8% support, but closing by Oct 30 hinges on Nasdaq listing approval and lender consents.

BYD fell 5.2% premarket as October retail sales dropped, following a 2.9% decline on CATL's miss. Analysts weigh sector weakness against company-specific updates.